Cannell & Spears’s Constellium CSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.3M Sell
909,200
-57,847
-6% -$1.38M 0.44% 63
2025
Q4
$18.2M Sell
967,047
-590,788
-38% -$9.81M 0.34% 79
2025
Q3
$23.2M Buy
1,557,835
+77,703
+5% +$1.11M 0.44% 67
2025
Q2
$19.7M Buy
1,480,132
+1,354,250
+1,076% +$15.2M 0.4% 74
2025
Q1
$1.27M Sell
125,882
-5,000
-4% -$53.1K 0.03% 215
2024
Q4
$1.34M Sell
130,882
-3,136,020
-96% -$38.6M 0.03% 212
2024
Q3
$53.1M Buy
3,266,902
+386,570
+13% +$6.56M 1.05% 27
2024
Q2
$54.3M Buy
2,880,332
+177,280
+7% +$3.69M 1.13% 30
2024
Q1
$59.8M Buy
+2,703,052
New +$52.3M 1.24% 21

Other funds holding CSTM

Cannell & Spears's CSTM Position: Q1 2026 in Review

Cannell & Spears reduced its Constellium (CSTM) stake by 6% in Q1 2026, selling an estimated $1.38M and leaving 909,200 shares worth $22.3M. The position accounts for 0.44% of the portfolio, ranked #63.

Cannell & Spears first reported a position in CSTM in Q1 2024 and has held it in 9 quarters since. The position peaked at $59.8M in Q1 2024. 313 funds tracked by Wall St. Rank hold CSTM as of Q1 2026.

  • Cannell & Spears held 909,200 shares of Constellium worth $22.3M as of Q1 2026.
  • Cannell & Spears sold 57,847 Constellium shares in Q1 2026, an estimated $1.38M.
  • Constellium made up 0.44% of Cannell & Spears's portfolio in Q1 2026, its #63 holding.
  • Cannell & Spears first reported a position in Constellium in Q1 2024 and has held it in 9 quarters since.
  • Cannell & Spears's Constellium position peaked at $59.8M in Q1 2024.
  • 313 funds tracked by Wall St. Rank held Constellium as of Q1 2026.

Based on Cannell & Spears's 13F filing for Q1 2026, filed 14 May 2026.